HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12058097.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration) is a rare syndrome with many clinical similarities to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). Despite these common features, lipoprotein abnormalities have not been reported in PKAN. After the recent discovery of the genetic defect in PKAN, we report a homozygous nonsense mutation in exon 5 of the PANK2 gene that creates a stop codon at amino acid 371 (R371X) in the original HARP patient. This finding establishes that HARP is part of the PKAN disease spectrum.
Medical subject headings
- Hypobetalipoproteinemias
- Neurodegenerative Diseases
- Pantothenate Kinase-Associated Neurodegeneration
- Phosphotransferases (Alcohol Group Acceptor)
- Retinitis Pigmentosa